BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. USO
2. SPY
3. TTAN
4. IONQ
5. QCOM
6. IONS
7. ROIV
8. ORCL
9. AAPL
10. HOOD

Go back to BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)

BeyondSpring (BYSI) to Resume Trading at 8:30 a.m.

December 1, 2021 8:17 AM EST

BeyondSpring (NASDAQ: BYSI) to Resume Trading at 8:30 a.m.

... More